Skip to main content

Abstract

Objective:

Forensic assertive community treatment (FACT) is an adaptation of the assertive community treatment model and is designed to serve justice-involved adults with serious mental illness. This study compared the effectiveness of a standardized FACT model and enhanced treatment as usual in reducing jail and hospital use and in promoting engagement in outpatient mental health services.

Methods:

Seventy adults with psychotic disorders who were arrested for misdemeanor crimes and who were eligible for conditional discharge were recruited from the Monroe County, New York, court system. Participants were randomly assigned to receive either FACT (N=35) or enhanced treatment as usual (N=35) for one year. Criminal justice and mental health service utilization outcomes were measured by using state and county databases.

Results:

Forty-nine participants (70%) completed the full one-year intervention period. Nineteen (27%) were removed early by judicial order, one was removed by county health authorities, and one died of a medical illness. Intent-to-treat analysis for all 70 participants showed that those receiving the FACT intervention had fewer mean±SD convictions (.4±.7 versus .9±1.3, p=.023), fewer mean days in jail (21.5±25.9 versus 43.5±59.2, p=.025), fewer mean days in the hospital (4.4±15.1 versus 23.8±64.2, p=.025), and more mean days in outpatient mental health treatment (305.5±92.1 versus 169.4±139.6, p<.001) compared with participants who received treatment as usual.

Conclusions:

The Rochester FACT model was associated with fewer convictions for new crimes, less time in jail and hospitals, and more time in outpatient treatment among justice-involved adults with psychotic disorders compared with treatment as usual.
Providing treatment for justice-involved adults with serious mental illness in outpatient mental health settings is challenging. Patients with histories of arrest and incarceration are often enrolled in assertive community treatment (ACT) programs (1), which are generally effective in preventing psychiatric hospitalization and promoting housing stability. However, ACT has not been found to be effective in reducing criminal justice system involvement (24).
Clinicians have subsequently adapted the ACT model in a wide variety of ways to serve patients who have repeated contact with the criminal justice system. These adaptations include using boundary spanners (5), hiring forensic peer specialists (6), providing trauma-informed treatment (7), providing residential treatment (8), partnering with police (9), and including probation officers as team members (10). ACT teams that specialize in serving justice-involved individuals have become known as forensic assertive community treatment (FACT) teams (11).
Published reviews of FACT have revealed great variability in program structure, daily operations, and treatment populations served (1214). Consequently, outcomes for these programs have been mixed. Some studies of FACT interventions have reported significantly reduced criminal justice system involvement (1519), others have failed to find consistently positive outcomes (20,21), and others have found evidence of increased jail recidivism (22). To address these disparate findings, a standardized FACT model was developed on the basis of a conceptual framework for preventing criminal recidivism among justice-involved adults with serious mental illness (23). Model development was also guided by experience with a prototype intervention (24) and by focus group input from FACT programs in three different states (25). In addition, consultation was obtained from experts in criminal justice, addiction treatment, psychiatric rehabilitation, and health psychology.
Based on this foundational work, the Rochester FACT model was established. The program consists of four components, including high-fidelity ACT provided by a team of criminal justice–savvy staff, identification and targeting of criminogenic risk factors, use of legal authority to promote engagement in necessary interventions (legal leverage), and mental health–criminal justice collaboration to promote effective problem solving. A 13-item fidelity scale (Forensic Assertive Community Treatment Scale [FACTS]) was subsequently developed to operationalize these components and to assess fidelity to the Rochester FACT model. [The fidelity scale is available as an online supplement to this article.]
This article presents results from a randomized controlled trial examining the effectiveness of the Rochester FACT model in reducing jail and hospital use and in promoting engagement in outpatient mental health services among individuals with a psychotic disorder and a history of criminal justice involvement.

Methods

Settings

The study took place at two primary sites, an academic medical center and a criminal court, in Monroe County, New York. All clinical interventions were based at Strong Ties Clinic, an outpatient program of the University of Rochester Medical Center (URMC) Department of Psychiatry. The clinic offers mental health services, primary medical care, and pharmacy services to all patients. Study recruitment was conducted at the Monroe County Courthouse, a public facility that houses Rochester City Court and attorney offices. Administrative approval was received from the New York State Office of Mental Health in November 2010 to begin initiating the research program at Strong Ties. The study was approved by the URMC Research Subject Review Board.

Study Design

A parallel-group randomized controlled design was used to assess service utilization outcomes over a one-year study period. Study inclusion criteria were ages 18 and older, presence of a DSM-IV-TR psychotic disorder, ability to speak English, adequate capacity to consent to research, recent conviction on a misdemeanor charge, and eligibility for a conditional discharge. All participants entered the study under a conditional discharge status, whereby their pre-enrollment sentences were suspended pending successful compliance with legal stipulations that included accepting mental health treatment and avoiding further criminal activity. Individuals involved in probation, parole, mental health court, assisted outpatient treatment, or other forms of legal leverage at the time of recruitment were excluded to enable comparison of leveraged (FACT) and nonleveraged treatment groups. Individuals facing felony charges were also excluded, but those with prior felony convictions were eligible for enrollment.

Recruitment and Randomization

A three-step process was utilized whereby potential study participants were first identified with assistance from the Public Defender’s office. Those who expressed interest in the study after pleading guilty and accepting a conditional discharge subsequently met with a research team member to provide informed consent in the presence of their defense attorneys. All participants consented to both the treatment intervention and the data collection arms of the study (26). Consenting individuals were then randomly assigned to a treatment group by using computer-generated assignment cards within a courtroom setting. [Participant identification, recruitment, and randomization are described in detail in an online supplement to this article.]

Baseline Assessment

Following randomization, participants were assessed at baseline. All baseline data were collected by the study health project coordinator, a research psychologist with ACT team experience. Baseline demographic data were obtained through face-to-face interviews and review of health records, and psychiatric diagnosis was confirmed by using the Structured Clinical Interview for DSM-IV-TR (27). Baseline clinical assessments included the Brief Psychiatric Rating Scale (BPRS) to assess symptoms (28), the Insight and Treatment Attitudes Questionnaire (ITAQ) to assess insight into need for treatment (29), the Medication Adherence Rating Scale (MARS) to assess medication adherence (30), the Addiction Severity Index (ASI) to assess severity of addiction (31), the Treatment Self-Regulation Questionnaire (TSRQ) to assess motivation for treatment (32), and the MacArthur Community Violence Inventory (MCVI) to assess involvement in violence as a victim or a perpetrator (33). To control for baseline recidivism risk, participants were also assessed with the Level of Service Inventory–Revised (LSI-R), an assessment tool shown to predict risk of reoffending (34).

Interventions

FACT.

The FACT intervention was based on a conceptual framework that uses legal leverage to engage justice-involved individuals in treatments and services that target criminogenic risk factors (23). FACT group participants received legal leverage in the form of judicial monitoring within a standard criminal court setting, and all were enrolled in a single treatment team. The FACT intervention’s ACT team component received a baseline score of 4.75 on the Dartmouth Assertive Community Treatment Scale, indicating high fidelity (35). The FACTS was subsequently used approximately six and 15 months after study initiation to assess intervention fidelity to the Rochester FACT model, with scores indicating high fidelity (4.69 and 4.61, respectively). FACT group clinicians conducted intake assessments that included review of available criminal justice and health records to identify risk factors for criminal recidivism, and they incorporated the risk factors into service plans for each participant. In preparation for study initiation, two authors (JSL and RLW) provided approximately six hours of instruction in mental health–criminal justice collaboration to all FACT group clinicians, the judge who monitored the FACT participants, and attorneys for the FACT participants. The FACTS was utilized as part of this training to provide an overview of the Rochester FACT model. To promote model implementation, the FACT team psychiatrist (RLW) provided additional training and support to all team clinicians in an informal and ongoing way during daily team meetings. Also, mental health and criminal justice service providers shared information about their respective roles, responsibilities, and service systems on an ongoing basis during judicial monitoring meetings.
A single Rochester City Court judge provided judicial oversight to all study participants. However, only FACT group participants received active judicial monitoring. The judicial-monitoring process included weekly meetings between a FACT team liaison, the presiding judge, and representatives from the Public Defender and District Attorney offices. The FACT team liaison provided participant progress reports for review at each meeting. Problems were actively discussed, potential solutions were identified, and intervention strategies were agreed upon prior to each participant’s court appearance. Weekly court appearances were initially required of all FACT group participants, with the frequency of subsequent meetings determined by the judge in collaboration with the FACT team liaison and attorneys.

Enhanced treatment as usual.

Participants in enhanced treatment as usual (control group) received outpatient mental health treatment from teams that included a psychiatrist or nurse practitioner for pharmacotherapy, a licensed clinical social worker for supportive therapy, and a case manager. Participants were not scheduled to see the presiding judge until a return date nine months after their study enrollment. Of note, outpatient mental health clinics in the Rochester area had waiting lists for new patients ranging from one to three months at the time of study initiation. All control group participants were given intake appointments at Strong Ties Clinic within five business days of randomization as a service enhancement to ensure comparable access to care. Service enhancement was required by federal law governing research with prisoners as a vulnerable population (36).

Outcome Measures

The New York State Division of Criminal Justice Services (NYS DCJS) provided statewide criminal justice service utilization data for all participants, including arrest, conviction, and sentencing data (37). Incarceration data on all participants was obtained from the Monroe County Sherriff’s Office, which oversees the 1,475-bed Monroe County jail (38). Mental health service utilization data were obtained from the Monroe County Mental Health Service (MCMHS) database (39). MCMHS is a countywide system that spans all publicly funded mental health agencies in Monroe County. Data provided by MCMHS contained psychiatric hospitalization, emergency room, and outpatient service use data for all participants. All data sets were provided in deidentified electronic formats with common participant identification numbers that enabled linking for data analysis.

Statistical Analysis

A Poisson regression model was used to detect changes in jail time, the primary outcome measure, between the two treatment groups. The study sample size allowed detection of an 11% or greater change in the average number of jail days during a one-year follow-up period with 80% power and a type 1 error rate of 5% for a two-sided hypothesis test. The observed effect size substantially exceeded 11%, indicating sufficient power to detect such an outcome. Baseline categorical variables are presented as summary counts and percentages, and differences between the baseline variables of the treatment groups were analyzed by either Fisher’s exact test for 2×2 matrices or Pearson’s chi-square test with Yates’ continuity correction. For continuous variables, the means, standard deviations, and p values resulting from Wilcoxon’s rank sum test with a continuity correction are presented. In cases where variables contained one or more missing values, the number of participants with complete data is presented. Analyses examining the association between baseline variables and failed conditional discharge status are summarized. Participants with a failed conditional discharge were removed from the intervention arm of the study protocol for failing to comply with the judge’s legal conditions but were continued in the data collection arm. These univariate analyses were conducted by using logistic regression analyses, with the reported p values coming from a likelihood ratio test of whether the baseline variable had an effect (versus no effect) on the odds of failed conditional discharge status. These analyses did not account for possible differences in duration of conditional discharge status, only whether or not a failed conditional discharge occurred during the study period.
Analyses were also performed to test the study hypotheses that FACT would have a greater effect than enhanced treatment as usual in preventing jail and psychiatric hospital use and in promoting outpatient mental health service use. The effect of FACT upon service utilization outcomes is summarized through regression coefficients, p values, and confidence intervals. Because each outcome measure could be viewed as a count, a negative binomial regression model was used to conduct these analyses. Analyses examined full one-year outcomes for all participants, including those who exited the study intervention arm early, using a constant offset equal to the natural logarithm of 365 days (“intent-to-treat” analyses). Additional analyses were conducted to examine outcomes only while participants were enrolled in the intervention arm of the study protocol by using an offset equal to the natural logarithm of days in protocol (“per-protocol” analyses). The p values for both intent-to-treat and per-protocol analyses are presented. Also, an exploratory analysis was conducted by using stepwise backward elimination to identify baseline variables most predictive of study outcomes (40) [see supplement for details of this analysis].

Results

Study Procedures and Follow-Up

All recruitment and study intervention activities were conducted between February 10, 2011, and May 14, 2014. Seventy participants were randomly assigned to receive either FACT (N=35) or enhanced treatment as usual (N=35) for one year. Forty-nine participants (70%) remained in the study intervention arm for one full year. Nineteen participants (27%), including nine from the FACT group and ten from the control group, were removed from the intervention arm by the judge for failing to comply with the conditions of discharge (that is, for demonstrating continuous treatment nonadherence combined with continuous criminal activity). One additional participant was removed from the control group by the county mental health director after the participant assaulted a nurse and a security guard while hospitalized. Individuals who failed to meet the terms of the conditional discharge were required to serve their original sentences, had no further judicial oversight, and became eligible for treatments other than the study treatment as determined by their treating clinicians. One FACT group participant died of medical causes unrelated to study participation. [A CONSORT diagram illustrating the flow of participants through the study is available in the online supplement.]
For all 70 study participants, the mean±SD number of days in the intervention arm of the study protocol was 329.7±67.0. The mean number of days in the intervention arm of the protocol was 326.8±78.6 for the FACT group and 332.5±53.9 for the control group, a nonsignificant difference.
Descriptive analyses of study variables, both overall and by intervention group, are shown in Table 1. Study participants had considerable impairment and a significant degree of criminal justice system involvement at baseline. Participants were predominantly male, African American, never married, and unemployed, and nearly half had not graduated from high school. The most common diagnosis was schizophrenia, and 70% of participants self-reported having a co-occurring substance use disorder. On average, participants spent over two months in jail during the year before enrollment and had over 16 lifetime arrests. Also, 30% of those interviewed with the MCVI (N=17 of 56) reported perpetrating violence toward others that resulted in injury during the six months before enrollment. Mean total BPRS scores indicated that participants had a moderate level of symptomatology, and mean total ITAQ scores suggested that they had only partial insight into their illnesses and the need for treatment. Mean total MARS scores showed that participants had low levels of medication adherence at baseline. Mean ASI scores suggested that overall addiction severity was in the low range. LSI-R scores indicated that participants had a moderate risk of criminal recidivism. Mean TSRQ scores showed that after randomization, there was a trend for participants in the control group to feel greater autonomy in deciding whether to take antipsychotic medications compared with participants in the FACT group. There were no significant differences between study groups in any baseline measure.
TABLE 1. Baseline characteristics of study participants randomly assigned to forensic assertive community treatment (FACT) or enhanced treatment as usual (control)
 Total (N=70)FACT (N=35)Control (N=35) 
CharacteristicN responsesN%N responsesN%N responsesN%p
Age (M±SD)7037.5±11.6 3537.7±12.1 3533.7±10.8 .169a
Gender70  35  35  1.00a
 Male 4361 2263 2160 
 Female 2739 1337 1440 
Race-ethnicity70  35  35  .299b
 African American 5173 2366 2880 
 Caucasian 1319 926 411 
 Hispanic 68 39 39 
Marital status70  35  35  1.00b
 Never married 5984 3086 2983 
 Divorced 1116 514 617 
Highest level of education62  34  28  .451c
 Did not graduate high school 2947 1442 1554 
 Graduated high school 2032 1132 932 
 Post high school 1321 927 414 
Employment70  35  35  .607b
 Unemployed 6694 3291 3497 
 Employed (paid, full- and part-time) 46 39 13 
Primary diagnosis70  35  35  .379b
 Schizophrenia 3651 1851 1851 
 Depression with psychotic features 1319 926 411 
 Schizoaffective disorder 811 26 617 
 Psychotic disorder, NOS 710 39 411 
 Bipolar disorder with psychotic features 69 39 39 
 Co-occurring substance use disorder70  35  35  .778c
 Polysubstance use 3246 1543 1749 
 None 2130 1234 926 
 Marijuana 1014 411 617 
 Cocaine 710 411 39 
Days homeless (M±SD)d5828.4±59.2 3423.1±50.9 2435.9±70.0 .276a
BPRS (M±SD)e5839.0±7.2 3439.7±7.7 2437.9±6.3 .192a
ITAQ (M±SD)f5715.4±5.8 3314.3±6.4 2416.8±4.7 .208a
MARS (M±SD)g543.4±2.6 323.6±2.6 223.1±2.6 .593a
ASI, alcohol (M±SD)h58.1±.2 34.1±.2 24.1±.2 .853a
ASI, drugs (M±SD)i57.1±.1 34.1±.1 23.1±.1 .980a
TSRQ autonomy subscale (M±SD)j565.67±1.55 335.38±1.70 236.09±1.23 .073a
LSI-R (M±SD)k5625.7±7.5 3326.0±7.1 2325.2±8.1 .881a
Lifetime arrests (M±SD)7016.3±20.6 3517.6±24.2 3514.9±16.5 .621a
Lifetime conviction (M±SD)707.9±11.9 359.0±13.6 356.9±10.1 .392a
Hospital days (M±SD)l,m708.3±22.9 357.5±17.0 358.9±27.8 .461a
Jail days (M±SD)l7070.0±90.2 3568.6±97.4 3565.4±83.8 .986a
Lifetime jail days (sentenced) (M±SD)70547±1079 35625±1,327 35468±767 .681a
Lifetime months of probation (sentenced) (M±SD)7039.0±46.9 3543.2±52.3 3534.9±41.2 .730a
a
Based on Wilcoxon’s rank sum with continuity correction test
b
Based on Fisher’s exact test for 2×2 matrices
c
Based on Pearson’s chi-square test with Yates’ continuity correction
d
During six months prior to enrollment
e
Brief Psychiatric Rating Scale (total score). Possible scores range from 18 to 126, with higher scores indicating greater symptom severity.
f
Insight and Treatment Attitudes Questionnaire (total score). Possible scores range from 0 to 22, with higher scores indicating greater insight into need for treatment.
g
Medication Adherence Rating Scale (total score). Possible scores range from 0 to 10, with higher scores indicating higher levels of medication adherence.
h
Addiction Severity Index. Scores for study participants ranged from 0 to .70, with higher scores indicating greater severity of alcohol addiction.
i
Addiction Severity Index. Scores for study participants ranged from 0 to .47, with higher scores indicating greater severity of drug addiction.
j
Treatment Self-Regulation Questionnaire. Possible scores range from 1 to 7, with higher scores indicating higher levels of perceived autonomy related to taking antipsychotic medications.
k
Level of Service Inventory–Revised (total score). Possible scores range from 0 to 54, with higher scores indicating greater risk of criminal recidivism.
l
During the year prior to enrollment
m
Includes days in both general and state psychiatric hospitals
Baseline characteristics of participants who received a failed conditional discharges and those who did not were compared. As shown in Table 2, individuals with failed conditional discharges had higher LSI-R scores and more severe psychiatric symptoms at baseline compared with individuals with successful conditional discharges. There was also a trend among the participants with failed conditional discharges to have been sentenced to a higher number of lifetime jail days at baseline than participants with successful conditional discharges (p=.060).
TABLE 2. Baseline characteristics of study participants, by failed conditional discharge statusa
 Failed conditional discharge
 No (N=50)Yes (N=20)
CharacteristicN responsesN%N responsesN%pb
Age (M±SD)5035.5±12.3 2036.4±9.8 .752
Gender50  20  .697
 Male 3060 1365 
 Female 2040 735 
Race-ethnicity50  20  .116
 African American 4080 1155 
 Caucasian 714 630 
 Hispanic 36 315 
Marital status50  20  .389
 Never married 4182 1890 
 Divorced 918 210 
Highest level of education43  19  .248
 Did not graduate high school 2252 737 
 Graduated high school 1125 947 
 Post high school 1023 316 
Employment50  20  .095
 Unemployed 4692 20100 
 Employed (paid, full- and part-time) 48 00 
Primary diagnosis50  20  .435
 Schizophrenia 2856 840 
 Depression with psychotic features 1020 315 
 Schizoaffective disorder 48 420 
 Psychotic disorder, NOS 510 210 
 Bipolar disorder with psychotic features 36 315 
Co-occurring substance use disorder50     .308
 Polysubstance use 2040 1260 
 None 1836 315 
 Marijuana 714 315 
 Cocaine 510 210 
Days homelessc4126.8±64.6 1732.4±44.9 .745
BPRS (M±SD)d4137.6±7.0 1742.4±6.6 .018
ITAQ (M±SD)e4015.6±6.1 1714.8±5.3 .655
MARS (M±SD)f373.0±2.1 174.2±3.4 .109
ASI, alcohol (M±SD)g41.1±.2 17.2±.2 .119
ASI, drugs (M±SD)h40.1±.1 17.1±.1 .696
TSRQ autonomy subscale (M±SD)i395.8±1.4 175.3±1.8 .289
LSI-R (M±SD)j4023.3±6.6 1631.6±6.4 <.001
Lifetime arrests5014.4±21.0 2021.0±19.3 .244
Lifetime convictions506.4±11.4 2011.8±12.7 .104
Hospital daysk,l505.9±13.4 2014.1±37.3 .200
Jail daysk5055.8±86.2 2094.9±96.2 .116
Lifetime jail days (sentenced) (M±SD)50388±1012 20943±1,163 .060
Lifetime months of probation (sentenced) (M±SD)5036.5±44.6 2045.5±52.9 .472
a
Participants with a failed conditional discharge were removed from the intervention arm of the study protocol for failing to comply with the judge’s legal conditions but were continued in the data collection arm.
b
Based on a likelihood ratio test (beta=0) in a logistic regression of whether the variable had an effect (versus no effect) on failed conditional discharge status
c
During 6 months prior to enrollment
d
Brief Psychiatric Rating Scale (total score). Possible scores range from 18 to 126, with higher scores indicating greater symptom severity.
e
Insight and Treatment Attitudes Questionnaire (total score). Possible scores range from 0 to 22, with higher scores indicating greater insight into need for treatment.
f
Medication Adherence Rating Scale (total score). Possible scores range from 0 to 10, with higher scores indicating higher levels of medication adherence.
g
Addiction Severity Index. Scores for study participants ranged from 0 to .70, with higher scores indicating greater severity of alcohol addiction.
h
Addiction Severity Index. Scores for study participants ranged from 0 to .47, with higher scores indicating greater severity of drug addiction.
i
Treatment Self-Regulation Questionnaire. Possible scores range from 1 to 7, with higher scores indicating higher levels of perceived autonomy related to taking antipsychotic medications.
j
Level of Service Inventory–Revised (total score). Possible scores range from 0 to 54, with higher scores indicating greater risk of criminal recidivism.
k
During the year prior to enrollment
l
Includes days in both general and state psychiatric hospitals

Effectiveness Outcomes

State and county databases enabled both intent-to-treat and per-protocol analyses of service utilization outcomes. As shown in Table 3, these analyses produced very similar results. FACT group participants had fewer criminal convictions and spent fewer days in jail than control group participants. FACT group participants also spent more time in outpatient treatment and had more outpatient service contacts compared with control group recipients. In addition, FACT participants had less use of inpatient psychiatric services compared with control group participants. No significant differences were observed between the groups in numbers of emergency room visits, arrests, or incarcerations. However, approximately one-third of all FACT group incarcerations were due to judicial sanctions for noncompliance rather than new crimes. Analyses of incarceration data with and without sanction incarcerations are included in Table 3. Also, one FACT group participant had 50 emergency room visits, more than all other FACT participants combined. With this outlier removed, FACT group participants had significantly fewer emergency room visits compared with control group participants (.8±1.6 and 1.9±2.7, respectively; coefficient=–.93, standard error=.43, p=.030).
TABLE 3. Comparison of criminal justice and service use outcomes for study participants randomly assigned to forensic assertive community treatment (FACT) or enhanced treatment as usual (control)a
 TotalFACTControlPer-protocol analysisIntent-to-treat analysis
OutcomeMSDMSDMSDCoef.±MEpCoef.±MEp
Total arrests1.11.5.81.31.31.7–.53±.74.165–.50±.68.159
Total convictions.71.1.4.7.91.3–.88±.77.028–.86±.72.023
N of incarcerations1.92.32.32.31.52.2.52±.62.105.42±.56.151
N of incarcerations minus sanction incarcerations1.41.91.31.51.52.2–.11±.62.967–.16±.60.602
Days in jail32.546.721.525.943.559.2–.62±.63.056–.71±.60.025
N of emergency room visits1.83.91.64.81.92.7–.18±1.2.778–.19±1.1.728
N of hospitalizationsb.61.2.3.7.81.4–1.1±1.1.051–1.1±1.0.042
Days in hospitalc14.147.34.415.123.864.2–1.69±1.4.018–1.68±1.4.025
Days in treatmentd237.5135.9305.592.1169.4139.6.64±.27<.001.59±.29<.001
Outpatient treatment contactse63.065.3112.059.314.114.52.1±.37<.0012.1±.38<.001
a
Effect sizes and p values are from negative binomial regression of variables in the per-protocol and intent-to-treat analyses. The coefficient (coef.) is the estimated effect size (estimated regression coefficient). The margin of error (ME) is 1.96 times the estimated standard error of the regression coefficient. Variables in the per-protocol analysis were analyzed by using the period of eligibility to receive treatment as the offset. Variables in the intent-to-treat analysis were analyzed without an offset.
b
Includes hospitalizations in both general and state psychiatric hospitals
c
Includes days in both general and state psychiatric hospitals
d
Days between group assignment and participants’ last contact with treatment providers
e
Includes all face-to-face contacts with FACT team members in the FACT group and all face-to-face contacts with treatment team members and with case managers in the control group

Discussion

This study presents findings from the first randomized controlled trial of a standardized FACT intervention. Three randomized controlled trials of FACT interventions have been published previously, each featuring a FACT intervention that simply combined ACT with a mental health court (20) or probation (21,22). That approach failed to significantly reduce either conviction rates or time spent in jail; to the contrary, one study reported increased bookings (20) and another study reported greater jail recidivism (22). These findings are consistent with the observation by Redlich and colleagues (41) that “offenders who receive more intensive monitoring (e.g., via assertive community treatment teams) have higher reincarceration rates . . . than those receiving less intensive monitoring.” However, this pattern was not observed in this study.
Like other FACT-type interventions, the Rochester FACT model is an adaptation of the ACT model. However, it targets criminogenic risk factors, incorporates legal leverage to promote engagement, and utilizes mental health–criminal justice collaboration to promote effective problem solving. These elements and their implementation distinguish the Rochester model from other FACT-type interventions and from the standard ACT model in clinical practice (11,42,43). By targeting the drivers of crime, emphasizing shared problem solving, and avoiding overreliance on punishment, the Rochester FACT model represents a criminologically informed hybrid of ACT, containing both clinical and criminal justice components. The study findings that FACT participants had fewer convictions for new crimes and less time in jail provide evidence of the model’s effectiveness in preventing criminal justice system involvement. However, these results raise the question of how the findings were achieved without concomitant reductions in arrest or incarceration rates compared with the control group.
One possible explanation is the FACT judge’s use of graduated sanctions, including bench warrants and brief incarceration, to address problem behaviors. Bench warrants were issued for arrest of FACT participants who missed court appointments in order to reengage rather than punish them. Because these arrests were not associated with new crimes, this strategy may explain, at least in part, why FACT participants had similar numbers of arrests but fewer convictions compared with the control group. Also, approximately a third of FACT group incarcerations were due to use of brief incarceration as a graduated sanction after less restrictive alternatives had failed. Because these incarcerations were short compared with incarcerations for new crimes, typically less than a week, their use was probably a factor in why FACT participants spent less time in jail compared with the control group despite having a similar number of incarcerations.
It is also possible that criminal justice outcomes may have been affected by the collaboration between FACT team clinicians and the judge. Rather than utilizing clinicians simply to report behavior problems, a process that can lead to increased incarceration (22,41,4447), the Rochester FACT model features problem-solving approaches, including the use of therapeutic alternatives to punishment (48). Collaborative problem solving could potentially have led to fewer convictions by the FACT group judge and less jail time among the FACT participants compared with control group participants without affecting the actual incidence of new crimes.
Criminal justice outcomes may also have been affected by factors beyond the role of the study judge. It is possible that the effectiveness of the Rochester FACT model, like all jail diversion interventions, depends less upon the method of diversion than upon the services that patients receive after jail diversion (4951). FACT team clinicians in this study worked to address the criminogenic risk factors driving each participant’s criminal justice system involvement. For example, FACT clinicians received training in cognitive-behavioral treatment for antisocial personality (52,53), and they conducted weekly groups to address participants’ antisocial cognitions and behaviors as part of the study intervention (54). Addressing criminogenic risk factors is a core principle of effective correctional rehabilitation for offenders who do not have a mental illness (5557), and employing this principle may also lead to crime reduction among offenders with a mental illness (5860). However, study data did not permit determination of the extent to which the results were attributable to each of the possibilities discussed above or to other factors.
The positive study results were obtained even though the treatment provided to the control group was probably superior to standard outpatient mental health treatment. The control group received enhanced access to outpatient treatment along with case management and on-site medical and pharmacy services. In addition, the study population appeared to be at higher risk of criminal justice system involvement compared with individuals who are typically served by jail diversion programs (51,61). However, the results should be interpreted with caution because of several methodological limitations, including a small sample size, missing baseline data, lack of detail about the distribution of service contacts, and lack of outcome data beyond service utilization. In the absence of clinical outcome data, for instance, it is unclear whether participants’ symptoms actually improved, although improvement is suggested by significant reductions in the hospitalization rate in the FACT group. It is also possible that the study’s positive outcomes were due to differences in the frequency of outpatient treatment contacts between the groups rather than the FACT model per se. Last, this research required active collaboration between the investigators and a judge, and the difficulties inherent in establishing such collaborative relationships may present a challenge to study reproducibility.

Conclusions

Study participants with severe mental illness and misdemeanor convictions who received the Rochester FACT model had fewer convictions for new crimes, spent less time in jail and hospitals, and spent more time in outpatient treatment compared with those who received enhanced treatment as usual. Further research is needed to refine the core components of the FACT intervention and to examine service utilization, clinical outcomes, and cost effectiveness among a range of study populations.

Acknowledgments

The authors acknowledge Edward J. Latessa, Ph.D., Steven Belenko, Ph.D., and John E. Elliott, J.D., for their consultation and support.

Footnote

All study activities, including design, conduct, data analysis, and interpretation, are the sole responsibility of the authors and do not represent the views of the National Institute of Mental Health, the Monroe County Office of Mental Health, the Monroe County Sherriff’s Office, or the New York State Division of Criminal Justice Services.

Supplementary Material

File (appi.ps.201600329.ds001.pdf)

References

1.
Beach C, Dykema LR, Appelbaum PS, et al: Forensic and nonforensic clients in assertive community treatment: a longitudinal study. Psychiatric Services 64:437–444, 2013
2.
Mueser KT, Bond GR, Drake RE, et al: Models of community care for severe mental illness: a review of research on case management. Schizophrenia Bulletin 24:37–74, 1998
3.
Bond GR, Drake RE, Mueser KT, et al: Assertive community treatment for people with severe mental illness: critical ingredients and impact on patients. Disease Management and Health Outcomes 9:141–159, 2001
4.
Calsyn RJ, Yonker RD, Lemming MR, et al: Impact of assertive community treatment and client characteristics on criminal justice outcomes in dual disorder homeless individuals. Criminal Behaviour and Mental Health 15:236–248, 2005
5.
Steadman HJ: Boundary spanners: a key component for effective interactions of the justice and mental health systems. Law and Human Behavior 16:75–87, 1992
6.
Davidson L, Rowe M: Peer Support Within Criminal Justice Settings: The Role of Forensic Peer Specialists. Delmar, NY, CMHS National GAINS Center, 2008
7.
Freeman D, Lautar A: Trauma-Specific Interventions for Justice-Involved Individuals. Delmar, NY, SAMHSA National GAINS Center, 2015
8.
Jennings J: Does assertive community treatment work with forensic populations? review and recommendations. Open Psychiatry Journal 3:13–19, 2009
9.
Improving Police Response to Persons With Mental Illness. Alexandria, VA, International Association of Chiefs of Police, 2010. http://www.theiacp.org/portals/0/pdfs/ImprovingPoliceResponsetoPersonsWithMentalIllnessSummit.pdf
10.
Lamberti JS, Deem A, Weisman RL, et al: The role of probation in forensic assertive community treatment. Psychiatric Services 62:418–421, 2011
11.
Lamberti JS, Weisman R, Faden DI: Forensic assertive community treatment: preventing incarceration of adults with severe mental illness. Psychiatric Services 55:1285–1293, 2004
12.
Lamberti JS, Weisman RL: Forensic assertive community treatment: origins, current practice, and future directions; in Reentry Planning for Offenders With Mental Disorders. Edited by Dlugacz HA. Kingston, NJ, Civic Research Institute, 2010
13.
Morrissey J, Meyer P, Cuddeback G: Extending assertive community treatment to criminal justice settings: origins, current evidence, and future directions. Community Mental Health Journal 43:527–544, 2007
14.
Cuddeback GS, Morrissey JP, Cusak KJ: Challenges to developing forensic assertive community treatment. American Journal of Psychiatric Rehabilitation 12:225–246, 2009
15.
Wilson D, Tien G, Eaves D: Increasing the community tenure of mentally disordered offenders: an assertive case management program. International Journal of Law and Psychiatry 18:61–69, 1995
16.
Cimino T, Jenkins JL: Arkansas partnership program: an innovative continuum of care program for dually diagnosed forensic patients. Psychiatric Rehabilitation Skills 6:104–114, 2002
17.
McCoy ML, Roberts DL, Hanrahan P, et al: Jail linkage assertive community treatment services for individuals with mental illnesses. Psychiatric Rehabilitation Journal 27:243–250, 2004
18.
Weisman RL, Lamberti JS, Price N: Integrating criminal justice, community healthcare, and support services for adults with severe mental disorders. Psychiatric Quarterly 75:71–85, 2004
19.
Mentally Ill Offender Crime Reduction Grant Program: Overview of Statewide Evaluation Findings. Sacramento, California Board of Corrections, 2005. http://sd15.senate.ca.gov/sites/sd15.senate.ca.gov/files/7b.pdf
20.
Cosden M, Ellens J, Schnell J, et al: Efficacy of a mental health treatment court with assertive community treatment. Behavioral Sciences and the Law 23:199–214, 2005
21.
Cusack KJ, Morrissey JP, Cuddeback GS, et al: Criminal justice involvement, behavioral health service use, and costs of forensic assertive community treatment: a randomized trial. Community Mental Health Journal 46:356–363, 2010
22.
Solomon P, Draine J: One-year outcomes of a randomized trial of case management with seriously mentally ill clients leaving jail. Evaluation Review 19:256–273, 1995
23.
Lamberti JS: Understanding and preventing criminal recidivism among adults with psychotic disorders. Psychiatric Services 58:773–781, 2007
24.
Gold Award: prevention of jail and hospital recidivism among persons with severe mental illness. Psychiatric Services 50:1477–1480, 1999
25.
Lamberti JS, Russ A, Cerulli C, et al: Patient experiences of autonomy and coercion while receiving legal leverage in forensic assertive community treatment. Harvard Review of Psychiatry 22:222–230, 2014
26.
Jeste DV, Palmer BW, Appelbaum PS, et al: A new brief instrument for assessing decisional capacity for clinical research. Archives of General Psychiatry 64:966–974, 2007
27.
First M, Spitzer R, Gibbon M, et al: Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Ed (SCID-I/NP). New York, New York State Psychiatric Institute, Biometrics Research Department, 2002
28.
Overall J, Gorham D: The Brief Psychiatric Scale; in ECDEU Assessment Manual for Psychopharmacology. Edited by Guy W. Rockville, MD, US Department of Health, Education and Welfare, 1976
29.
McEvoy JP, Aland J Jr, Wilson WH, et al: Measuring chronic schizophrenic patients’ attitudes toward their illness and treatment. Hospital and Community Psychiatry 32:856–858, 1981
30.
Thompson K, Kulkarni J, Sergejew AA: Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophrenia Research 42:241–247, 2000
31.
McLellan AT, Luborsky L, Woody GE, et al: An improved diagnostic evaluation instrument for substance abuse patients: the Addiction Severity Index. Journal of Nervous and Mental Disease 168:26–33, 1980
32.
Levesque CS, Williams GC, Elliot D, et al: Validating the theoretical structure of the Treatment Self-Regulation Questionnaire (TSRQ) across three different health behaviors. Health Education Research 22:691–702, 2007
33.
Steadman HJ, Mulvey EP, Monahan J, et al: Violence by people discharged from acute psychiatric inpatient facilities and by others in the same neighborhoods. Archives of General Psychiatry 55:393–401, 1998
34.
Andrews DA, Bonta J: The Level of Service Inventory–Revised. Toronto, Multi-Health Systems, 1995
35.
Teague GB, Bond GR, Drake RE: Program fidelity in assertive community treatment: development and use of a measure. American Journal of Orthopsychiatry 68:216–232, 1998
36.
Additional protections pertaining to biomedical and behavioral research involving prisoners as subjects. Code of Federal Regulations Title 45, Part 46, Subpart C. Washington, DC, US Department of Health and Human Services, 2009. http://www.hhs.gov/ohrp/regulations-and-policy/regulations/45-cfr-46/index.html#subpartc
37.
Access to Criminal History Records. Albany, NY, Division of Criminal Justice Services. Accessed May 10, 2017. http://www.criminaljustice.ny.gov/ojis/recordreview.htm
38.
County Jail Census Report. Rochester, NY, Monroe County.gov. Accessed May 10, 2017. http://www2.monroecounty.gov/sheriff-jailbureau
39.
Statistics and Reports. Rochester, NY, Monroe County Office of Mental Health. Accessed May 10, 2017. http://www2.monroecounty.gov/mh-statistics-reports-new.php
40.
Hurvich CM, Tsai CL: The impact of model selection on inference in linear regression. American Statistician 44:214–217, 1990
41.
Redlich AD, Steadman HJ, Monahan J, et al: Patterns of practice in mental health courts: a national survey. Law and Human Behavior 30:347–362, 2006
42.
Rosen A, Mueser KT, Teesson M: Assertive community treatment—issues from scientific and clinical literature with implications for practice. Journal of Rehabilitation Research and Development 44:813–825, 2007
43.
Test MA, Stein LI: In reply: a critique of the effectiveness of assertive community treatment. Psychiatric Services 52:1396, 2001
44.
Draine J, Solomon P: Threats of incarceration in a psychiatric probation and parole service. American Journal of Orthopsychiatry 71:262–267, 2001
45.
Manchak SM, Skeem JL, Kennealy PJ, et al: High-fidelity specialty mental health probation improves officer practices, treatment access, and rule compliance. Law and Human Behavior 38:450–461, 2014
46.
Lowenkamp CT, Flores AW, Holsinger AM, et al: Intensive supervision programs: does program philosophy and the principles of effective intervention matter? Journal of Criminal Justice 38:368–375, 2010
47.
Slate RN, Buffington-Vollum JK, Johnson WW: The Criminalization of Mental Illness. Crisis and Opportunity for the Justice System, 2nd ed. Durham, NC, Carolina Academic Press, 2013
48.
Lamberti JS: Preventing criminal recidivism through mental health and criminal justice collaboration. Psychiatric Services 67:1206–1212, 2016
49.
Lange S, Rehm J, Popova S: The effectiveness of criminal justice diversion initiatives in North America: a systematic literature review. International Journal of Forensic Mental Health 10:200–214, 2011
50.
Scott DA, McGilloway S, Dempster M, et al: Effectiveness of criminal justice liaison and diversion services for offenders with mental disorders: a review. Psychiatric Services 64:843–849, 2013
51.
Case B, Steadman HJ, Dupuis SA, et al: Who succeeds in jail diversion programs for persons with mental illness? A multi-site study. Behavioral Sciences and the Law 27:661–674, 2009
52.
Little GL, Robinson KD: Moral reconation therapy: a systematic step-by-step treatment system for treatment resistant clients. Psychological Reports 62:135–151, 1988
53.
Little GL: Meta-analysis of moral reconation therapy: recidivism results from probation and parole implementations. Cognitive-Behavioral Treatment Review 14:14–16, 2005
54.
Muxworthy H, Timberlake A: Treating antisocial personality disorder with moral reconation therapy within the community mental health center. Presented at the American Psychiatric Nurses Association annual conference, Pittsburgh, Nov 7–10, 2012
55.
Latessa EJ, Listwan SL, Koetzle D: What Works (and Doesn’t) in Reducing Recidivism. Waltham, MA, Anderson, 2014
56.
Gendreau P: The principles of effective intervention with offenders; in Choosing Correctional Options That Work: Defining the Demand and Evaluating the Supply. Edited by Harland AT. Thousand Oaks, CA, Sage, 1996
57.
Andrews DA, Bonta J: The Psychology of Criminal Conduct, 5th ed. New York, Routledge, 2010
58.
Skeem JL, Steadman HJ, Manchak SM: Applicability of the risk-need-responsivity model to persons with mental illness involved in the criminal justice system. Psychiatric Services 66:916–922, 2015
59.
Skeem JL, Winter E, Kennealy PJ, et al: Offenders with mental illness have criminogenic needs, too: toward recidivism reduction. Law and Human Behavior 38:212–224, 2014
60.
Rotter M, Carr WA: Targeting criminal recidivism in mentally ill offenders: structured clinical approaches. Community Mental Health Journal 47:723–726, 2011
61.
Steadman HJ, Naples M: Assessing the effectiveness of jail diversion programs for persons with serious mental illness and co-occurring substance use disorders. Behavioral Sciences and the Law 23:163–170, 2005

Information & Authors

Information

Published In

Go to Psychiatric Services
Go to Psychiatric Services

Cover: Birmingham Breakdown #2, by Craig Moran, 2010. Oil on canvas. Collection of the artist, Washington, D.C.

Psychiatric Services
Pages: 1016 - 1024
PubMed: 28566028

History

Received: 15 July 2016
Revision received: 14 November 2016
Revision received: 13 February 2017
Accepted: 13 March 2017
Published online: 1 June 2017
Published in print: October 01, 2017

Keywords

  1. Assertive community treatment, Difficult patients, Law &amp
  2. psychiatry, Mental illness &amp
  3. alcohol/drug abuse, Research/service delivery

Authors

Details

J. Steven Lamberti, M.D. [email protected]
Dr. Lamberti, Dr. Weisman, Dr. Cerulli, Mr. Jacobowitz, and Dr. Caine are with the Department of Psychiatry, Dr. Williams is with the Department of Medicine and the Department of Clinical and Social Sciences in Psychology, Dr. Strawderman and Mr. Harrington are with the Department of Biostatistics and Computational Biology, and Ms. Lamberti is with the School of Nursing, all at the University of Rochester Medical Center, Rochester, New York. Dr. Mueser is with the Center for Psychiatric Rehabilitation, Boston University, Boston. Judge Marks (ret.) is with the Monroe County Courts, Rochester, New York.
Robert L. Weisman, D.O.
Dr. Lamberti, Dr. Weisman, Dr. Cerulli, Mr. Jacobowitz, and Dr. Caine are with the Department of Psychiatry, Dr. Williams is with the Department of Medicine and the Department of Clinical and Social Sciences in Psychology, Dr. Strawderman and Mr. Harrington are with the Department of Biostatistics and Computational Biology, and Ms. Lamberti is with the School of Nursing, all at the University of Rochester Medical Center, Rochester, New York. Dr. Mueser is with the Center for Psychiatric Rehabilitation, Boston University, Boston. Judge Marks (ret.) is with the Monroe County Courts, Rochester, New York.
Catherine Cerulli, J.D., Ph.D.
Dr. Lamberti, Dr. Weisman, Dr. Cerulli, Mr. Jacobowitz, and Dr. Caine are with the Department of Psychiatry, Dr. Williams is with the Department of Medicine and the Department of Clinical and Social Sciences in Psychology, Dr. Strawderman and Mr. Harrington are with the Department of Biostatistics and Computational Biology, and Ms. Lamberti is with the School of Nursing, all at the University of Rochester Medical Center, Rochester, New York. Dr. Mueser is with the Center for Psychiatric Rehabilitation, Boston University, Boston. Judge Marks (ret.) is with the Monroe County Courts, Rochester, New York.
Geoffrey C. Williams, M.D., Ph.D.
Dr. Lamberti, Dr. Weisman, Dr. Cerulli, Mr. Jacobowitz, and Dr. Caine are with the Department of Psychiatry, Dr. Williams is with the Department of Medicine and the Department of Clinical and Social Sciences in Psychology, Dr. Strawderman and Mr. Harrington are with the Department of Biostatistics and Computational Biology, and Ms. Lamberti is with the School of Nursing, all at the University of Rochester Medical Center, Rochester, New York. Dr. Mueser is with the Center for Psychiatric Rehabilitation, Boston University, Boston. Judge Marks (ret.) is with the Monroe County Courts, Rochester, New York.
David B. Jacobowitz, B.S., M.A.
Dr. Lamberti, Dr. Weisman, Dr. Cerulli, Mr. Jacobowitz, and Dr. Caine are with the Department of Psychiatry, Dr. Williams is with the Department of Medicine and the Department of Clinical and Social Sciences in Psychology, Dr. Strawderman and Mr. Harrington are with the Department of Biostatistics and Computational Biology, and Ms. Lamberti is with the School of Nursing, all at the University of Rochester Medical Center, Rochester, New York. Dr. Mueser is with the Center for Psychiatric Rehabilitation, Boston University, Boston. Judge Marks (ret.) is with the Monroe County Courts, Rochester, New York.
Kim T. Mueser, Ph.D.
Dr. Lamberti, Dr. Weisman, Dr. Cerulli, Mr. Jacobowitz, and Dr. Caine are with the Department of Psychiatry, Dr. Williams is with the Department of Medicine and the Department of Clinical and Social Sciences in Psychology, Dr. Strawderman and Mr. Harrington are with the Department of Biostatistics and Computational Biology, and Ms. Lamberti is with the School of Nursing, all at the University of Rochester Medical Center, Rochester, New York. Dr. Mueser is with the Center for Psychiatric Rehabilitation, Boston University, Boston. Judge Marks (ret.) is with the Monroe County Courts, Rochester, New York.
Patricia D. Marks, J.D.
Dr. Lamberti, Dr. Weisman, Dr. Cerulli, Mr. Jacobowitz, and Dr. Caine are with the Department of Psychiatry, Dr. Williams is with the Department of Medicine and the Department of Clinical and Social Sciences in Psychology, Dr. Strawderman and Mr. Harrington are with the Department of Biostatistics and Computational Biology, and Ms. Lamberti is with the School of Nursing, all at the University of Rochester Medical Center, Rochester, New York. Dr. Mueser is with the Center for Psychiatric Rehabilitation, Boston University, Boston. Judge Marks (ret.) is with the Monroe County Courts, Rochester, New York.
Robert L. Strawderman, Sc.D.
Dr. Lamberti, Dr. Weisman, Dr. Cerulli, Mr. Jacobowitz, and Dr. Caine are with the Department of Psychiatry, Dr. Williams is with the Department of Medicine and the Department of Clinical and Social Sciences in Psychology, Dr. Strawderman and Mr. Harrington are with the Department of Biostatistics and Computational Biology, and Ms. Lamberti is with the School of Nursing, all at the University of Rochester Medical Center, Rochester, New York. Dr. Mueser is with the Center for Psychiatric Rehabilitation, Boston University, Boston. Judge Marks (ret.) is with the Monroe County Courts, Rochester, New York.
Donald Harrington, M.S.
Dr. Lamberti, Dr. Weisman, Dr. Cerulli, Mr. Jacobowitz, and Dr. Caine are with the Department of Psychiatry, Dr. Williams is with the Department of Medicine and the Department of Clinical and Social Sciences in Psychology, Dr. Strawderman and Mr. Harrington are with the Department of Biostatistics and Computational Biology, and Ms. Lamberti is with the School of Nursing, all at the University of Rochester Medical Center, Rochester, New York. Dr. Mueser is with the Center for Psychiatric Rehabilitation, Boston University, Boston. Judge Marks (ret.) is with the Monroe County Courts, Rochester, New York.
Tara A. Lamberti, B.A. [email protected]
Dr. Lamberti, Dr. Weisman, Dr. Cerulli, Mr. Jacobowitz, and Dr. Caine are with the Department of Psychiatry, Dr. Williams is with the Department of Medicine and the Department of Clinical and Social Sciences in Psychology, Dr. Strawderman and Mr. Harrington are with the Department of Biostatistics and Computational Biology, and Ms. Lamberti is with the School of Nursing, all at the University of Rochester Medical Center, Rochester, New York. Dr. Mueser is with the Center for Psychiatric Rehabilitation, Boston University, Boston. Judge Marks (ret.) is with the Monroe County Courts, Rochester, New York.
Eric D. Caine, M.D.
Dr. Lamberti, Dr. Weisman, Dr. Cerulli, Mr. Jacobowitz, and Dr. Caine are with the Department of Psychiatry, Dr. Williams is with the Department of Medicine and the Department of Clinical and Social Sciences in Psychology, Dr. Strawderman and Mr. Harrington are with the Department of Biostatistics and Computational Biology, and Ms. Lamberti is with the School of Nursing, all at the University of Rochester Medical Center, Rochester, New York. Dr. Mueser is with the Center for Psychiatric Rehabilitation, Boston University, Boston. Judge Marks (ret.) is with the Monroe County Courts, Rochester, New York.

Notes

Send correspondence to Dr. Lamberti (e-mail: [email protected]).

Competing Interests

Dr. Lamberti and Dr. Weisman are owners of Community Forensic Interventions, L.L.C., a company that provides training and technical assistance in community-based care of justice-involved adults with serious mental illness, which includes licensing agreements with the University of Rochester Medical Center. Dr. Williams reports equity ownership in Self-Determined Health ending in 2016. He is a member of the Pfizer speaker’s bureau for Chantix and is a consultant for MAD*POW. The other authors report no financial relationships with commercial interests.

Funding Information

National Institute of Mental Health10.13039/100000025: R34-MH078003-01A
The study was supported by grant R34-MH078003-01A from the National Institute of Mental Health.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/ePub

View PDF/ePub

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Psychiatric Services

PPV Articles - Psychiatric Services

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share